<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-pathogens-09-00231">
 <label>59.</label>
 <element-citation publication-type="web">
  <article-title>Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.gilead.com/news-and-press/press-room/press-releases/2020/2/gilead-sciences-initiates-two-phase-3-studies-of-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.gilead.com/news-and-press/press-room/press-releases/2020/2/gilead-sciences-initiates-two-phase-3-studies-of-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-02-27">(accessed on 27 February 2020)</date-in-citation>
 </element-citation>
</ref>
